Consumer products giant Johnson & Johnson (NYSE:JNJ) continues to demonstrate why it may be one of the highest-quality companies in the world. J&J, the world's largest maker of healthcare products, reported a 9% uptick in sales in the 2009 fourth quarter. Net profit was 79 cents per share, down 20% due to one-time restructuring charges. Net income from operations would have been $1.02 absent such charges. The full year earnings number came in at $4.40 a share on sales of $62 billion, down 5% and 3% respectively.

IN PICTURES: Eight Ways To Survive A Market Downturn

The Bigger Picture
Johnson and Johnson may well be one of the most recession resistant companies in the world. Despite this, the company couldn't avoid a sales decline in 2009, even though a 3% drop would be the envy of most other businesses. Before the impact of the Great Recession, J&J had had a decades long streak of reporting both an increase in sales and earnings. And while the company's current size prevents it from nailing down the stunning growth figures it produced in its early years, J&J continues to have a bright long-term future. The company's products - things like Tylenol, Band-Aids and baby shampoo - have nearly unlimited growth potential in international markets. (For more, see Recession-Proof Your Portfolio.)

As Good as It Gets
Like any company, J&J has its competitive pressures. Its pharmaceutical products have to contend with generic competition and in 2009, the company's medical devices division was down due to a drop in elective surgical procedures. But the company's long-term appeal is one found in only a handful of names like Coca-Cola (NYSE:KO) and Procter and Gamble (NYSE:PG). These businesses have products with continuous global appeal supported by brands that control markets. And today, a quality name like Johnson and Johnson trades for less than 14 times earnings and yields 3%. Compare this with iconic retailers Nordstrom (NYSE:JWN) and Tiffany's (NYSE:TIF), both wonderful brands, but with valuations of 22 and 33 times earnings and half the dividend yield.

Bottom Line
Despite the market's performance in 2009, the economy is still very fragile. But products like J&J's are often at the top of consumer lists, so this company stands a better chance than most of weathering this storm with its armor intact. (For more, see 3 Secrets Of Successful Companies.)

Related Articles
  1. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  2. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  3. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  4. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  5. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  6. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
  7. Stock Analysis

    Why Alphabet is the Best of the 'FANGs' for 2016

    Alphabet just impressed the street, but is it the best FANG stock?
  8. Investing News

    A 2016 Outlook: What January 2009 Can Teach Us

    January 2009 and January 2016 were similar from an investment standpoint, but from a forward-looking perspective, they were very different.
  9. Mutual Funds & ETFs

    3 Vanguard Equity Fund Underperformers

    Discover three funds from Vanguard Group that consistently underperform their indexes. Learn how consistent most Vanguard low-fee funds are at matching their indexes.
  10. Investing News

    Alphabet Earnings Beat Expectations (GOOGL, AAPL)

    Alphabet's earnings crush analysts' expectations; now bigger than Apple?
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
Trading Center